Literature DB >> 11278323

Cloning and biological activity of epigen, a novel member of the epidermal growth factor superfamily.

L Strachan1, J G Murison, R L Prestidge, M A Sleeman, J D Watson, K D Kumble.   

Abstract

High throughput sequencing of a mouse keratinocyte library was used to identify an expressed sequence tag with homology to the epidermal growth factor (EGF) family of growth factors. We have named the protein encoded by this expressed sequence tag Epigen, for epithelial mitogen. Epigen encodes a protein of 152 amino acids that contains features characteristic of the EGF superfamily. Two hydrophobic regions, corresponding to a putative signal sequence and transmembrane domain, flank a core of amino acids encompassing six cysteine residues and two putative N-linked glycosylation sites. Epigen shows 24-37% identity to members of the EGF superfamily including EGF, transforming growth factor alpha, and Epiregulin. Northern blotting of several adult mouse tissues indicated that Epigen was present in testis, heart, and liver. Recombinant Epigen was synthesized in Escherichia coli and refolded, and its biological activity was compared with that of EGF and transforming growth factor alpha in several assays. In epithelial cells, Epigen stimulated the phosphorylation of c-erbB-1 and mitogen-activated protein kinases and also activated a reporter gene containing enhancer sequences present in the c-fos promoter. Epigen also stimulated the proliferation of HaCaT cells, and this proliferation was blocked by an antibody to the extracellular domain of the receptor tyrosine kinase c-erbB-1. Thus, Epigen is the newest member of the EGF superfamily and, with its ability to promote the growth of epithelial cells, may constitute a novel molecular target for wound-healing therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278323     DOI: 10.1074/jbc.M006935200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Receptor-based antidote for diphtheria.

Authors:  Jeong-Heon Cha; Joanna S Brooke; Mee Young Chang; Leon Eidels
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

2.  Phenotypic variation resulting from a deficiency of epidermal growth factor receptor in mice is caused by extensive genetic heterogeneity that can be genetically and molecularly partitioned.

Authors:  Karen E Strunk; Vicky Amann; David W Threadgill
Journal:  Genetics       Date:  2004-08       Impact factor: 4.562

3.  Amphiregulin carboxy-terminal domain is required for autocrine keratinocyte growth.

Authors:  Stefan W Stoll; Jessica L Johnson; Yong Li; Laure Rittié; James T Elder
Journal:  J Invest Dermatol       Date:  2010-04-29       Impact factor: 8.551

Review 4.  At the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of bone.

Authors:  John Foley; Nicole Nickerson; David J Riese; Peter C Hollenhorst; Gwendolen Lorch; Anne M Foley
Journal:  Odontology       Date:  2012-06-10       Impact factor: 2.634

5.  Mechanical stretch promotes fetal type II epithelial cell differentiation via shedding of HB-EGF and TGF-alpha.

Authors:  Yulian Wang; Benjamin S Maciejewski; Dariana Soto-Reyes; Hyeon-Soo Lee; David Warburton; Juan Sanchez-Esteban
Journal:  J Physiol       Date:  2009-02-23       Impact factor: 5.182

Review 6.  Trafficking of epidermal growth factor receptor ligands in polarized epithelial cells.

Authors:  Bhuminder Singh; Robert J Coffey
Journal:  Annu Rev Physiol       Date:  2013-11-08       Impact factor: 19.318

7.  Metalloproteinase-mediated, context-dependent function of amphiregulin and HB-EGF in human keratinocytes and skin.

Authors:  Stefan W Stoll; Jessica L Johnson; Ajay Bhasin; Andrew Johnston; Johann E Gudjonsson; Laure Rittié; James T Elder
Journal:  J Invest Dermatol       Date:  2010-01       Impact factor: 8.551

8.  Mitogenic activity and signaling mechanism of 2-(14,15- epoxyeicosatrienoyl)glycerol, a novel cytochrome p450 arachidonate metabolite.

Authors:  Jianchun Chen; Jian-Kang Chen; John R Falck; Jagadeesh Setti Guthi; Siddam Anjaiah; Jorge H Capdevila; Raymond C Harris
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

9.  Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling.

Authors:  Leslie F Jackson; Ting Hu Qiu; Susan W Sunnarborg; Aileen Chang; Chunlian Zhang; Cam Patterson; David C Lee
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

10.  Autocrine-derived epidermal growth factor receptor ligands contribute to recruitment of tumor-associated macrophage and growth of basal breast cancer cells in vivo.

Authors:  Nicole K Nickerson; Christopher P Mill; Hsin-Jung Wu; David J Riese; John Foley
Journal:  Oncol Res       Date:  2013       Impact factor: 5.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.